×
0 0 0 0 0.0145348837209302 0.0145348837209302 0.0145348837209302 0.0174418604651163
Stockreport

Neurocrine Bio on go with H1 2019 filing of U.S. application for Parkinson's candidate opicapone [Seeking Alpha]

NEUROCRINE BIOSCIENCES (NBIX)  More Company Research Source: Seeking Alpha
Last neurocrine biosciences earnings: 7/31 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: neurocrine.com/about-us/webcasts-presentations
PDF Neurocrine Bio on go with H1 2019 filing of U.S. application for Parkinson's candidate opicaponeCiting FDA feedback, Neurocrine Biosciences (NASDAQ:NBIX) says itexpects to file a U.S. marketing application seeking approval for Parkinson's disease drug opicapone in H1 2019. It says the agency's Neurology Division has not requested another Phase 3 study prior to submission.The company secured exclusive North American rights to the medicine, branded as ONGENTYS, from Portuguese drug maker BIAL only a week ago.Previously:Neurocrine Bio nabs North American rights to PD med opicapone (Feb. 9, 2017)Click to subscribe to real-time analytics on NBIXNow read:PM Perspectives: Charting M&A; In Healthcare After Tax Reform » [Read more]

IMPACT SNAPSHOT EVENT TIME: NBIX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
NBIX alerts

from News Quantified
Opt-in for
NBIX alerts

from News Quantified